300181.SZ · 佐力药业
China A-shares · RS rating 48 · As of 2026-10-14
| Price | 13.17 CNY |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 70 / 48 / 31 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 22 / 19 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +31.1% |
| Market cap (USD) | $1.4B |